Orphan Drugs: Ready to Peak?

What’s the big deal about orphan drugs? Well, they form the fastest-growing segment of the pharma market and dominate FDA approvals for a start. The diseases they treat…

Cardiology: the heart of the matter

This infographic gives you the vital signs of the cardiology landscape. Get a snapshot of the key medtech approvals, the industry players that are driving cardiology…

Cardiology: the heart of the matter

This infographic gives you the vital signs of the cardiology landscape. Get a snapshot of the key medtech approvals, the industry players that are driving cardiology…

Obesity matters for drug developers

Close to 40% of the US adult population is now obese and the WHO and AMA define obesity as a disease. So it’s perhaps no surprise that Evaluate Pharma is forecasting…

Vantage logo
Independent, data-driven daily news and analysis on pharma, biotech and medtech.